Immix Biopharma, Inc. - Common Stock (IMMX)

CUSIP: 45258H106

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
52,769,253
Total 13F shares
783,068
Share change
+376,717
Total reported value
$5,326,329
Price per share
$6.92
Number of holders
28
Value change
+$2,756,459
Number of buys
19
Number of sells
4

Security key

45258H106

Report period

Q4 2023

Institutions

28

Top holders

10

Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Vladimir P. Torchilin
3/4/5
Scientific Co-Founder
class O/S missing
905,200
$4,230,905 20 Dec 2021
Sean Senn
3/4/5
Under 10% owner
class O/S missing
899,800
$4,205,665 14 Jul 2022
VANGUARD GROUP INC
13F
Company
0.2%
106,210
$363,238 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
73,022
$249,805 30 Sep 2023
13F
Koshinski Asset Management, Inc.
13F
Company
0.1%
51,001
$174,423 30 Sep 2023
13F
STATE STREET CORP
13F
Company
0.08%
42,960
$146,923 30 Sep 2023
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.05%
28,855
$99,000 30 Sep 2023
13F
Imprint Wealth LLC
13F
Company
0.04%
23,083
$78,944 30 Sep 2023
13F
Moss Adams Wealth Advisors LLC
13F
Company
0.04%
20,000
$68,400 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
0.03%
17,991
$61,529 30 Sep 2023
13F
InterOcean Capital Group, LLC
13F
Company
0.03%
15,900
$54,378 30 Sep 2023
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.02%
12,000
$41,040 30 Sep 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
11,915
$40,749 30 Sep 2023
13F
Tortoise Investment Management, LLC
13F
Company
0%
1,300
$4,446 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
0%
400
$1,368 30 Sep 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
350
$1,197 30 Sep 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
57
$195 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
0%
7
$24 30 Sep 2023
13F

Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q4 2023

As of 31 Dec 2023, Immix Biopharma, Inc. - Common Stock (IMMX) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 783,068 shares. The largest 10 holders included VANGUARD GROUP INC, EAM Investors, LLC, Private Advisor Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Imprint Wealth LLC, RENAISSANCE TECHNOLOGIES LLC, COMMONWEALTH EQUITY SERVICES, LLC, NORTHERN TRUST CORP, and Moss Adams Wealth Advisors LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
16
Q4 2023 holders
28
Holder diff
12
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .